PTPN11 and breast carcinoma: Experimental and clinical data have indicated that high levels of SHP2 mRNA correlate with poor progression-free survival and overall survival in lung adenocarcinomas (12) and SHP2 promotes tumor progression in many types of cancer including breast cancer (13).